HK1085656A1 - Use of cxcl6 chemokine in the prevention or repair of cartilage defects - Google Patents

Use of cxcl6 chemokine in the prevention or repair of cartilage defects

Info

Publication number
HK1085656A1
HK1085656A1 HK06105628.3A HK06105628A HK1085656A1 HK 1085656 A1 HK1085656 A1 HK 1085656A1 HK 06105628 A HK06105628 A HK 06105628A HK 1085656 A1 HK1085656 A1 HK 1085656A1
Authority
HK
Hong Kong
Prior art keywords
repair
cxcl6
prevention
cartilage
cartilage defects
Prior art date
Application number
HK06105628.3A
Other languages
English (en)
Inventor
Frank Luyten
Bari Cosimo De
Accio Francesco Dell
Original Assignee
Tigenix Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1085656(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tigenix Nv filed Critical Tigenix Nv
Publication of HK1085656A1 publication Critical patent/HK1085656A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK06105628.3A 2003-08-12 2006-05-16 Use of cxcl6 chemokine in the prevention or repair of cartilage defects HK1085656A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49451603P 2003-08-12 2003-08-12
PCT/BE2004/000117 WO2005014026A2 (en) 2003-08-12 2004-08-12 Use of cxcl6 chemokine in the prevention or repair of cartilage defects

Publications (1)

Publication Number Publication Date
HK1085656A1 true HK1085656A1 (en) 2006-09-01

Family

ID=34135345

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06105628.3A HK1085656A1 (en) 2003-08-12 2006-05-16 Use of cxcl6 chemokine in the prevention or repair of cartilage defects

Country Status (16)

Country Link
US (2) US7485310B2 (es)
EP (1) EP1653994B1 (es)
JP (1) JP4920412B2 (es)
AT (1) ATE449608T1 (es)
AU (1) AU2004262451B2 (es)
CA (1) CA2533124C (es)
DE (1) DE602004024312D1 (es)
DK (1) DK1653994T3 (es)
ES (1) ES2337469T3 (es)
HK (1) HK1085656A1 (es)
IL (1) IL173544A (es)
NO (1) NO338152B1 (es)
NZ (1) NZ545702A (es)
PL (1) PL1653994T3 (es)
RU (1) RU2363491C2 (es)
WO (1) WO2005014026A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
CA2708147A1 (en) * 2007-12-05 2009-06-18 Musculoskeletal Transplant Foundation Cancellous bone implant for cartilage repair
EP2265220A1 (en) 2008-03-05 2010-12-29 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US8466278B2 (en) 2008-09-22 2013-06-18 Arcarios B.V. Carboxyethylated cyclodextrin polysulfates useful as medicaments
GB0820492D0 (en) 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
DK2459224T3 (en) * 2009-07-27 2016-07-25 Baxalta GmbH Blodstørkningsproteinkonjugater
KR101223511B1 (ko) * 2009-10-23 2013-01-31 주식회사 알앤엘바이오 지방조직 유래 성체 줄기세포 이동을 유도하는 방법
US8687070B2 (en) 2009-12-22 2014-04-01 Apple Inc. Image capture device having tilt and/or perspective correction
EP2968134B1 (en) 2013-03-15 2021-09-01 W. L. Gore & Associates, Inc. Aqueous delivery system for low surface energy structures
CA2902226A1 (en) * 2013-03-29 2014-10-02 Merrimack Pharmaceuticals, Inc. Compositions and methods for treating osteolytic bone disorders
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN116904520B (zh) * 2023-09-13 2024-01-09 中国人民解放军军事科学院军事医学研究院 制备重组软骨祖细胞的方法及获得的重组软骨祖细胞与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413511B1 (en) 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
AU5628394A (en) * 1992-11-27 1994-06-22 Rega Institute Leuven University Granulocyte chemotactic protein
US5723331A (en) * 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
GB9502022D0 (en) 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US6410268B1 (en) * 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
DE19814405C2 (de) * 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
US6515001B2 (en) 2001-03-05 2003-02-04 Chemokine Therapeutic Corporation IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases
EP1444326A4 (en) * 2001-08-24 2006-06-28 Advanced Cell Tech Inc SCREENING ASSAYS FOR IDENTIFICATION OF AGENTS INDUCING DIFFERENTIATION, AND PRODUCTION OF CELLS DIFFERENTIATED FOR CELL THERAPY
EP1312614A1 (en) * 2001-11-16 2003-05-21 GenOdyssee Polynucleotides and polypeptides of the GCP-2 gene
JP2003199816A (ja) * 2002-01-10 2003-07-15 Takehisa Matsuda 軟骨組織再生用補助材、軟骨組織再生用キット及び軟骨組織再生方法
EP1541688B1 (en) * 2002-07-26 2012-09-05 Ajinomoto Co., Inc. Peptide synthase gene
PL1641914T3 (pl) * 2003-06-27 2017-01-31 DePuy Synthes Products, Inc. Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek

Also Published As

Publication number Publication date
RU2363491C2 (ru) 2009-08-10
ATE449608T1 (de) 2009-12-15
IL173544A0 (en) 2006-07-05
JP2007501807A (ja) 2007-02-01
US7485310B2 (en) 2009-02-03
DE602004024312D1 (de) 2010-01-07
RU2006107536A (ru) 2006-08-10
NZ545702A (en) 2008-08-29
NO20060464L (no) 2006-04-20
AU2004262451A1 (en) 2005-02-17
AU2004262451B2 (en) 2009-11-26
DK1653994T3 (da) 2010-03-15
ES2337469T3 (es) 2010-04-26
IL173544A (en) 2013-12-31
CA2533124A1 (en) 2005-02-17
WO2005014026A3 (en) 2005-03-17
CA2533124C (en) 2014-01-28
PL1653994T3 (pl) 2010-05-31
US20090117652A1 (en) 2009-05-07
WO2005014026A2 (en) 2005-02-17
EP1653994B1 (en) 2009-11-25
NO338152B1 (no) 2016-08-01
EP1653994A2 (en) 2006-05-10
US7842502B2 (en) 2010-11-30
US20060246031A1 (en) 2006-11-02
JP4920412B2 (ja) 2012-04-18

Similar Documents

Publication Publication Date Title
IL173544A0 (en) Use of cxcl6 chemokine in the prevention or repair of cartilage defects
GB2392674A (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
RS20080336A (en) Activin-actriia antagonists and uses for promoting bone growth
MX2021015070A (es) Inmunomodulacion usando celulas madre de la placenta.
SG152273A1 (en) Pdx1 expressing endoderm
DE602005015302D1 (en) Nkg2d modulation
MX2008007286A (es) Ingenieria in vivo de superficie celular.
WO2004044142A3 (en) Mesenchymal stem cells and methods of use thereof
ATE342962T1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
MY146518A (en) Methods to culture circovirus.
MX344970B (es) Medio de cultivo celular para la expresion de la proteina adamts.
WO2007044083A3 (en) Evolved interferon-alpha polypeptides
WO2006047743A8 (en) Swine multipotent adult progenitor cells
MX2009011319A (es) Adenosina desaminasa recombinante estable.
EP1702064A4 (en) BIOMETRIC COMPOSITION REINFORCED BY A POLYELECTROLYTIC COMPLEX OF HYALURONIC ACID AND CHITOSAN
EP1718733A4 (en) COMPOSITIONS AND METHODS FOR NEURAL STEM CELL CULTURE WITH STROMAL BONE MARROW CELLS
MX2007010332A (es) Metodos y composiciones para promover adhesion o migracion de celula endotelial.
MX2021012041A (es) Metodos para promover la diferenciacion de celulas epiteliales timicas y progenitores de celulas epiteliales timicas de celulas madre pluripotentes, celulas resultantes y usos de estas.
EP3133150A3 (en) Derivation of embryonic stem cells and embryo-derived cells
TW200728205A (en) Alumina particles and methods of making the same
EP2341147A3 (en) Preprimitive streak and mesendoderm cells
EP2985341A3 (en) Methods and compositions for modulating differentiation of pluripotential cells
WO2005017115A3 (en) Cord blood-derived hematopoietic progenitor cells
WO2005001033A3 (en) Tolerance induction and maintenance in hematopoietic stem cell allografts

Legal Events

Date Code Title Description
PS Patent surrendered
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190812

PS Patent surrendered